Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune Uveitis

Bortezomib is a proteasome inhibitor used for hematologic cancer treatment. Since it can suppress NF-κB activation, which is critical for the inflammatory process, bortezomib has been found to possess anti-inflammatory activity. In this study, we evaluated the effect of bortezomib on experimental au...

全面介紹

Na minha lista:
書目詳細資料
發表在:Mediators Inflamm
Main Authors: Hsu, Sheng-Min, Yang, Chang-Hao, Shen, Fang-Hsiu, Chen, Shun-Hua, Lin, Chia-Jhen, Shieh, Chi-Chang
格式: Artigo
語言:Inglês
出版: Hindawi Publishing Corporation 2015
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306382/
https://ncbi.nlm.nih.gov/pubmed/25653480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/847373
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍